Tekla Capital Management LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2023$14,778,297
+441.3%
324,370
+381.9%
0.58%
+455.8%
Q1 2023$2,730,175
-72.2%
67,312
-44.8%
0.10%
-71.7%
Q3 2020$9,813,000
-6.6%
122,0230.0%0.37%
-8.0%
Q2 2020$10,506,000
+33.2%
122,023
+25.6%
0.40%
+12.0%
Q1 2020$7,890,000
-27.4%
97,183
-25.2%
0.36%
-13.1%
Q4 2019$10,869,000
-24.7%
129,983
-21.2%
0.41%
-34.8%
Q3 2019$14,429,000
-0.3%
164,958
-6.6%
0.63%
+6.6%
Q2 2019$14,472,000
+29.3%
176,698
+28.4%
0.59%
+29.9%
Q1 2019$11,194,000
+5.5%
137,668
-14.6%
0.46%
+0.2%
Q4 2018$10,612,000
-5.7%
161,233
+10.4%
0.45%
+11.3%
Q3 2018$11,258,000
+13.7%
146,040
+8.9%
0.41%
+8.5%
Q2 2018$9,904,000
+281.1%
134,124
+235.6%
0.38%
+272.3%
Q1 2018$2,599,000
-80.2%
39,965
-87.5%
0.10%
-81.9%
Q1 2016$13,129,000
+7.7%
319,6000.0%0.56%
+26.2%
Q4 2015$12,193,000
+16.1%
319,6000.0%0.44%
+17.2%
Q3 2015$10,499,000
-53.0%
319,6000.0%0.38%
-53.4%
Q2 2015$22,350,000
+2.1%
319,6000.0%0.81%
-6.7%
Q1 2015$21,893,000
+329.1%
319,600
+311.5%
0.87%
+52.6%
Q3 2013$5,102,000
-5.2%
77,6750.0%0.57%
-22.4%
Q2 2013$5,381,00077,6750.73%
Other shareholders
BAXTER INTL INC shareholders Q1 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders